São Paulo, Brazil

Josue Bacaltchuk

This inventor holds 1 USPTO granted patent. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josue Bacaltchuk. Retrieved from https://idiyas.com/inventor/josue-bacaltchuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Josue Bacaltchuk: Innovator in Anticonvulsant Derivatives

Introduction

Josue Bacaltchuk is a notable inventor based in Sao Paulo, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticonvulsant derivatives. His work focuses on innovative treatments for depression, showcasing his commitment to improving mental health therapies.

Latest Patents

Josue Bacaltchuk holds 1 patent for his invention titled "Anticonvulsant derivatives useful for the treatment of depression." This patent discloses anticonvulsant derivatives that can be utilized as monotherapy or in combination therapy for treating depression. His research highlights the potential of these derivatives in enhancing treatment options for patients suffering from this condition.

Career Highlights

Bacaltchuk is currently associated with Ortho-McNeil Pharmaceutical Corporation, where he continues to innovate and develop new therapeutic solutions. His work at the company reflects his dedication to advancing pharmaceutical science and improving patient outcomes.

Collaborations

Throughout his career, Josue has collaborated with esteemed colleagues, including Carlos Plata-Salaman and Pedro A S Prado-Lima. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceuticals.

Conclusion

Josue Bacaltchuk's contributions to the development of anticonvulsant derivatives represent a significant advancement in the treatment of depression. His innovative approach and dedication to research continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…